- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 137.75M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.1B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.1B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $857M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $933M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.41B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.42B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.2B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.25B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.57B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.67B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.45B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $722M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $241M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 143.5M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $110M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $47M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$40M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$19M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $710M |